SCHEMBL7573134

SCHEMBL7573134

CCCc1cc(=O)c2cc(O)ccc2o1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.81
STS P08842 2/20 0.58
MAPT P10636 4/20 0.53
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
TP53 P04637 2/20 0.53
CYP3A4 P08684 2/20 0.53
HPGD P15428 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
LMNA P02545 1/20 0.53
THRB P10828 1/20 0.53
CASP3 P42574 1/20 0.53
SENP8 Q96LD8 1/20 0.53
SENP7 Q9BQF6 1/20 0.53
SENP6 Q9GZR1 1/20 0.53
IP6K2 Q9UHH9 1/20 0.53
CSNK2A2 P19784 2/20 0.51
CSNK2B P67870 2/20 0.51
CSNK2A1 P68400 2/20 0.51
LOXL2 Q9Y4K0 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7673826 0.91 ALOX15 (0.92) ALOX15STSMAPTNPC1RAB9A
SCHEMBL7573085 0.88 ALOX15 (0.97) ALOX15STSMAPTNPC1RAB9A
SCHEMBL12386444 0.83 STS (0.59) ALOX15STSRAB9ASMN1; SMN2CSNK2A2
SCHEMBL18397817 0.82 ALOX15 (0.64) ALOX15MAPTNPC1RAB9ATP53
SCHEMBL9431755 0.81 STS (0.58) ALOX15STSPPARG
SCHEMBL12325512 0.81 ALOX15 (0.62) ALOX15MAPTNPC1RAB9ATP53
SCHEMBL30335890 0.81 PPARG (0.71) ALOX15STSMAPTNPC1RAB9A
SCHEMBL27806527 0.81 PPARG (0.71) ALOX15STSMAPTNPC1RAB9A
SCHEMBL3661429 0.79 ALOX15 (0.72) ALOX15CYP3A4HPGDSMN1; SMN2IP6K2
SCHEMBL3715533 0.79 PPARG (0.69) ALOX15STSNPC1RAB9ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1070059-B1 CHROMANONE AND THIOCHROMANONE DERIVATIVES NOVARTIS AG (CH) 2002-09-25 EP disclosed
US-6346626-B1 DRUGS FOR TREATMENT OF SKIN DISORDERS SUCH AS ACNE, SEBORRHEA, ANDROGENIC ALOPECIA AND HIRSUTISM, OR IN THE TOPICAL TREATMENT OF SQUAMOUS CELL CARCINOMA NOVARTIS AG (CH) 2002-02-12 US disclosed
EP-1070059-A1 CHROMANONE AND THIOCHROMANONE DERIVATIVES Novartis AG (CH) 2001-01-24 EP disclosed
WO-1999052890-A1 CHROMANONE AND THIOCHROMANONE DERIVATIVES NOVARTIS AG (CH) 1999-10-21 WO disclosed